tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market
Advertisement

Biogen (BIIB) Technical Analysis

Compare
4,897 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is 2.25, suggesting Biogen is a Sell.
Biogen’s (BIIB) 20-Day exponential moving average is 134.60, while Biogen’s (BIIB) share price is $136.72, making it a Buy.
Biogen’s (BIIB) 50-Day exponential moving average is 132.06, while Biogen’s (BIIB) share price is $136.72, making it a Buy.

Biogen (BIIB) Pivot Points

Aug 28, 2025, 06:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
131.47
133.81
135.08
137.42
138.69
141.03
142.30
Fibonacci
133.81
135.19
136.04
137.42
138.80
139.65
141.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Aug 28, 2025, 06:14 PM
Period
Simple
Exponential
MA5
138.10Sell
137.35Sell
MA10
137.40Sell
136.50Buy
MA20
133.52Buy
134.60Buy
MA50
130.95Buy
132.06Buy
MA100
127.41Buy
133.12Buy
MA200
137.90Sell
144.33Sell
Biogen’s (BIIB) 10-Day exponential moving average is 136.50, while Biogen’s (BIIB) share price is $136.72, making it a Buy.
Biogen’s (BIIB) 100-Day exponential moving average is 133.12, while Biogen’s (BIIB) share price is $136.72, making it a Buy.
Biogen’s (BIIB) stock price is $136.72 and Biogen’s (BIIB) 50-day simple moving average is 130.95, creating a Buy signal.
Biogen’s (BIIB) stock price is $136.72 and Biogen’s (BIIB) 100-day simple moving average is 127.41, creating a Buy signal.
Biogen’s (BIIB) stock price is $136.72 and Biogen’s (BIIB) 200-day simple moving average is 137.90, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Aug 28, 2025, 06:14 PM
Name
Value
Implied Action
RSI (14)
56.17
Neutral
STOCH (9,6)
59.12
Neutral
STOCHRSI (14)
68.30
Neutral
MACD (12,26)
2.25
Sell
ADX (14)
19.31
Buy
Williams %R
-36.55
Buy
CCI (14)
47.85
Neutral
ATR (14)
3.78
-
Ultimate Oscillator
40.93
Neutral
ROC
5.71
Buy
Biogen’s (BIIB) Relative Strength Index (RSI) is 56.17, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 19.31, creating a Buy signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is 47.85, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is 5.71, creating a Buy signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Buy.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 56.17, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is 2.25, which suggests BIIB is a Sell.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 138.10, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 133.52, which suggests BIIB is a Buy.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 130.95, which suggests BIIB is a Buy.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 137.90, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -36.55, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is 47.85, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis